What are the risks of investing in LRMR?
L
What are the risks of investing in LRMR?
🦉
Larimar Therapeutics, Inc. (LRMR)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOCarole S. Ben-Maimon
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a...
Key Executives
| Name | Title |
|---|---|
| Carole S. Ben-Maimon | Chief Executive Officer, President & Director |
| Francis Michael Conway | Vice President & Controller |
| Gopi Shankar | Chief Development Officer |
| Jennifer Spokes Johansson | Vice President of Legal & Compliance |
| John Berman | Vice President of Finance & Administration |
| Michael Celano | Secretary & Chief Financial Officer |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A